Learn more

BEIJING INSTITUTE FOR CANCER RES

Overview
  • Total Patents
    21
  • GoodIP Patent Rank
    94,624
  • Filing trend
    ⇩ 60.0%
About

BEIJING INSTITUTE FOR CANCER RES has a total of 21 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2012. It filed its patents most often in China, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are BEIJING INST CANCER RES, STICHTING VUMC and INST CATALANA RECERCA ESTUDIS AVANCATS.

Patent filings per year

Chart showing BEIJING INSTITUTE FOR CANCER RESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhao Wei 4
#2 Wang Limin 3
#3 Liu Zhaojun 3
#4 Han Haibo 3
#5 Zhang Zhiqian 3
#6 Yang Wei 3
#7 Shou Chengchao 3
#8 Zhao Chuanke 3
#9 Xing Baocai 3
#10 Deng Dajun 3

Latest patents

Publication Filing date Title
AU2021100578A4 Use of thermosensitive material in preparation of injection for protecting perihepatic structure during thermal ablation
CN111899789A Method and system for identifying BRCA1/2 large fragment rearrangement by second-generation sequencing
CN111763736A Liquid biopsy kit for diagnosing thyroid papillary carcinoma lymph node metastasis
CN111549044A Preparation method and application of targeted TRBC1 CAR-T cell
CN111724903A System for predicting gastric cancer prognosis in a subject
CN111592584A HER2 affinity body and diagnosis and treatment nuclide marker as well as preparation method and application thereof
CN111533785A Targeting immune checkpoint TIM3 binding peptides and uses thereof
CN111696659A Medical insurance big data-based tumor morbidity information monitoring method and device
WO2021012149A1 Method and system for monitoring radiotherapy emitted beam
WO2020228009A1 Method for quantitatively detecting deletion of human cdkn2a gene copy, primers and use thereof
CN109481687A The combination of CDK4/6 inhibitor joint HER2 inhibitor for curing gastric cancer
CN108491460A Personally identifiable information matching process, device, storage medium and computer equipment
CN108085340A A kind of slow virus carrier of CAR and PD1-CD28 Chimerical receptor that is while expressing targeting CD19 and CD20
CN108623694A The derivative of vascular endothelial growth factor receptor antagonistic peptide F56 and application
CN108498500A New opplications of the Aiphanol in antitumor